Citation

88 FR 87435

Multiple canonical documents share this first-page citation.

Pharmacyclics LLC.; Withdrawal of Approval of Indications for Mantle Cell Lymphoma and Marginal Zone Lymphoma for IMBRUVICA (ibrutinib) Capsules and Tablets Monday, December 18, 2023 88 FR 87435
Funding Opportunity for the Community Opioid Intervention Prevention Program Monday, December 18, 2023 88 FR 87435